ANN ARBOR, Mich.--(BUSINESS WIRE)--Michigan Technology and Research Institute (MITRI) today announced the launch of their DNA testing for human clinical trials, with an emphasis on inflammatory diseases and mechanistic studies of adverse drug reactions.
